表达红细胞前期疟原虫抗原的诺如病毒病毒样颗粒诱导针对子孢子感染的功能性免疫
研究利用保留 protruding(P)结构但缺失天然壳(S)域的诺如病毒亚病毒颗粒作为疫苗载体,展示恶性疟原虫 CelTOS 和 CSP 表位,在小鼠挑战模型中评估免疫原性和保护力;展示 PfCelTOS 表位的颗粒诱导无菌保护,展示 PfCSP 表位的颗粒诱导在体外肝阶段发育试验(ILSDA)中具有抗子孢子功能活性的抗体。
要点
- 诺如病毒 P 颗粒展示 PfCelTOS 表位在小鼠中诱导无菌保护。
- 展示 PfCSP 表位的 P 颗粒诱导的抗体在 ILSDA 中具有抗子孢子功能活性。
- 结果支持进一步评估该平台作为疫苗递送系统。
核心结论
- 表达 PfCelTOS 或 PfCSP 表位的诺如病毒 P 颗粒在小鼠中诱导保护性免疫或功能性抗体,结果支持进一步评估该平台作为疫苗递送系统。
研究设计与样本
- 研究使用缺失天然壳(S)域但保留 protruding(P)结构的诺如病毒亚病毒颗粒作为疫苗载体,展示恶性疟原虫 CelTOS 和 CSP 表位,在小鼠挑战模型中评估免疫原性和保护力。
主要发现
- 展示 PfCelTOS 表位的 P 颗粒在小鼠中诱导无菌保护。
- 展示 PfCSP 表位的 P 颗粒诱导的抗体在体外肝阶段发育试验(ILSDA)中具有抗子孢子功能活性。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the development of prophylactic anti-malarial drugs and practices to prevent infection, malaria remains a health concern. Preclinical testing of novel malaria vaccine strategies achieved through rational antigen selection and novel particle-based delivery platforms is yielding encouraging results. One such platform, self-assembling virus-like particles (VLP) is safer than attenuated live viruses, and has been approved as a vaccination tool by the FDA. We explore the use of Norovirus sub-viral particles lacking the natural shell (S) domain forming the interior shell but that retain the protruding (P) structures of the native virus as a vaccine vector. Epitope selection and their surface display has the potential to focus antigen specific immune responses to crucial epitopes. Recombinant P-particles displaying epitopes from two malaria antigens, Plasmodium falciparum (Pf) CelTOS and Plasmodium falciparum (Pf) CSP, were evaluated for immunogenicity and their ability to confer protection in a murine challenge model. Immune responses induced in mice resulted either in sterile protection (displaying PfCelTOS epitopes) or in antibodies with functional activity against sporozoites (displaying PfCSP epitopes) in an in vitro liver-stage development assay (ILSDA). These results are encouraging and support further evaluation of this platform as a vaccine delivery system.
引用
- Schneider CG, Fey J, Zou X, et al. Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. Vaccine. 2022. PMID: 35697572. doi:10.1016/j.vaccine.2022.05.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。